INTRODUCTION
strains derived from both RA and nonrheumatoid (NR) synovial membranes have been established from explants and studied for viruses and mycoplasmas. Neither mycoplasmas nor viruses were found by direct tests, interference tests, or by radio-labeling the nucleic acids (1) (2) (3) (4) . To further examine RA synovial cells for an infectious agent, synovial cells have been used as target cells in cytotoxic tests, by the reasoning that if a virus, mycoplasma, or induced antigen were present on synovial cells, RA lymphocytes might be cytotoxic to synovial target cells. These methods should allow for the detection of any synovial cell differences, if present, irrespective of the origin of the antigen(s) ; i.e., be it a neo-antigen, auto-antigen, microbial, transplantation, tissue specific, fetal, or other antigen.
With both unseparated peripheral blood leukocytes and isolated peripheral blood lymphocytes, comparisons were made between aggressor cells from patients with RA, other diseases, primarily connective tissue diseases (CTD), and normal persons, and between RA and NR synovial cells as target cells. This report presents data that demonstrate that lymphocytes from patients with RA were significantly more toxic for RA-derived synovial cells than for NR synovial cells.
METHODS
Target cell cultures. Cell cultures were established as previously described, with Eagle's minimum essential medium containing 10% fetal calf serum, 0.75 g/liter sodium bicarbonate, 100 U/ml penicillin, 100 /Ag/ml streptomycin, and 50 U/ml mycostatin (1, 4) . The synovial cells were derived from 18 patients with RA, two patients with degenerative joint disease, two patients with aseptic necrosis of the femoral head (one with gouty arthritis and the other with hemoglobin sickle cell disease), two patients with noninflammatory knee effusions (one thought to be secondary to trauma, the other thought to have pseudogout clinically), and one patient with an osteocartilaginous loose body in the knee (secondary to trauma). Human by gravity for 1-3 h at 360C, and the letkocytes were collected from the plasma and washed three times with Hanks' balanced salt solution. The concentration of white blood cells in the final suspension was adjusted to 2 x 10' viable cells/ml after a sample was counted and tested for viability with trypan blue.
Source and preparation of purified lymphocytes. Lymphocytes were obtained from patients with RA and normal laboratory personnel. 6-8 ml of heparinized whole blood (8 U heparin/ml blood) were layered on 5 ml of FicollHypaque, prepared by mixing 24 parts of an aqueous 9%o (wt/vol) solution of Ficoll (Sigma Chemical Co., St. Louis, Mo.) with 10 parts of a 33.9% (wt/vol) aqueous solution of Hypaque sodium (brand of sodium diatrizoate, Winthrop Laboratories, New York). The specimens were centrifuged at 400 g in a swinging bucket rotor for 20 min at ambient temperature (5) . The white band of mononuclear cells was collected and the cells were washed three times with Hanks' balanced salt solution with centrifugations at 50-70 g for 10 min each. After the third wash, the cell pellet was suspended in 1 ml of Eagle's minimum essential medium, supplemented with sodium bicarbonate, antibiotics, and 10% fetal bovine serum. All glassware used to this point was siliconized (Siliclad, Clay Adams, Div. of Becton, Dickinson & Co., Parsippany, N. J.). The cell suspensions were then allowed to attach to the walls of 1-oz soft glass prescription bottles at 360C for 30-60 min. Nonadherent cells The following day the Ficoll-Hypaque-separated lymphocy,tes were suspended in medium to contain 2 x 105 lymphocytes/ml and 0.1 ml was added to six wells containing each target cell strain, giving aggressor: target cell ratio of 100: 1. Each test usually included lymphocytes from five patients with RA and two control subjects. Eagle's medium was added to six wells containing target cells only, which served as target cell controls. No guinea pig serum was used in any test with lymphocytes. All of the plates were covered and reincubated overnight. The microtiter plates were processed as described for the leukocyte microcytotoxicity assay except that safranin 0 (2.5 g safranin 0 per 100 ml 95% ethyl alcohol, diluted 1: 10 in distilled water and mixed with an equal volume of formalin-saline) was used to stain the surviving target cells.
Microcytotoxicity assay: experimental and theoretical considerations. Obtaining reproducible results in the microcytotoxic assay was found to depend on an optimal number of target cells in each well, so that valid comparisons. could be made between control and test wells in each experiment. The optimal number of target cells is one which can be easily and reproducibly counted and sufficiently large so that "in-test" variability is a relatively small percent of mean number of cells in the control wells. In preliminary experiments to determine the optimum, 50, 100, 200, 500, and 1,000 target cells were planted in 12 wells of a microtiter plate, incubated for 48 h, and counted. Seeding 500 or more cells resulted in so many target cells that counting was difficult. Planting 100 cells or fewer yielded only about 9-18 cells/well because of the plating efficiency of our strains. Since this small number of target cells would require a higher percent killing to be detected, we chose to use 200 target cells in the standard microcy,totoxicity assay. ' Person, D. A., and J. T. Sharp. Unpublished observations.
One of our early concerns related to the plating efficiency of the synovial target cells under the conditions of the cytotoxic assay. The design of the assay permitted a determination of the actual plating efficiency of the target cells used in each experiment, and no differences were found between RA and NR target cells. Based on the mean plating efficiencies, 32-36 individual target cells were present and countable in each control well when 200 cells were planted.
Other investigators have studied various aggressor-totarget cell ratios, ranging from less than 1: 1 to 5,000: 1. In general, 10: 1, 100: 1, and 500: 1 aggressor-to-target cell ratios have been used most often.
Initially aggressor-to-target cell ratios of 100: 1 and 10: 1 were chosen for the studies with leukocyte aggressor cells because these ratios were within the range usually used by others, and using two different leukocyte concentrations allowed an evaluation of possible dose-related effects.
It should be noted that the stated ratios of aggressor to target cells of 100: 1 and 10: 1 were based on the number of target cells seeded, a practice customary in cytotoxic assays. However, based on the determined plating efficiencies, the actual aggressor-to-target cell ratios were on the order of 600: 1 and 60: 1.
The lymphocytotoxic tests were set up after the results of the leukocyte cytotoxic tests were available and only 100: 1 lymphocyte: target cell ratios were studied. In view of the usual differential count on whole leukocyte suspensions, the lymphocyte: target cell ratios were two to three times higher in the tests using separated lymphocytes than irn those using suspensions of unseparated leukocytes.
Statistical methods. The design of each test run and the statistical appraisal of cytotoxicity were intended to account for the important technical variables that could influence the outcome. The location of disease or control aggressor cells in the microtiter wells was continually varied and was unknown to the individual who counted surviving cells, so that results of cell counts could not be unconsciously influenced. Mean cell counts, standard deviations, and standard errors of the six wells containing the same aggressor and target cells were calculated. The differences between the mean of control and test sets were analyzed by the t test (6) . Percent cytotoxicity was also calculated, with the control set as 0% killing. 50 unselected, consecutive tests were plotted to show the relationship of percent killing to the calculated value of t (Fig. 1) . Regression analysis demonstrated a close fit, with r2 = 0.94.
We have chosen to express the bulk of the results reported here in terms of the t value rather than percent killing, since we believe the t test better accounts for variability from day to day and within a given day's run. However, it should be noted that the results would not be different in terms of comparisons between RA and NR target or aggressor cells if we had chosen to express the results in terms of percent killing. From the plot of the regression analysis ( Fig. 1) , it can be seen that 28%o killing produced a t of 2.1 (P < 0.05) and 40% killing gave a t of 2.9 (P < 0.01).
Since the t value in any given cytotoxic assay reflected the extent of killing, the value for t could be treated as a "cytotoxic score." Thus individual t values were termed the cytotoxic score to avoid confusion with comparisons made between the results obtained in the different patient groups with the t test for two means.
Chi-square (x') analysis was performed by Fisher's exact method, and linear regression analysis by the least squares method was calculated with a programmed calculator (HP-65, Hewlett-Packard Co., Palo Alto, Calif.).
Mycoplasina isolation attempts. The target cells and extracellular fluids were tested for mycoplasmal contamination with pleuropneumonia-like organism agar plates without inhibitors. Incubation was at 36°C under both aerobic and anaerobic conditions. Most of the tissues from which the cell strains were derived were cultured for mycoplasmas upon receipt in the laboratory. All cultures were negative. In addition, several of the target cell strains were studied with radioactive nucleotides as a probe for viral or mycoplasmal nucleic acid, and none was found (4). all sources were more cytotoxic for NR synovial target cells than for HEL cells (Table II) . At the 100: 1 ratios, the differences between RA leukocytes and control leukocytes were significant, with t of 2.56 (P < 0.02, df 137), and the differences between other leukocytes and control leukocytes were not significant, with t of 1.83 (P > 0.05, df 128). Differences between RA and other patients' leukocytes were not significant (t = 1.24, P > 0.2, df 165). As with the HEL target cells, tests with NR target cells failed to detect significant differences between leukocytes from different patient groups (Table IV) . Lymphocytotoxicity: NR synovial target ceUs. NR synovial cells were used as target cells in 127 assays with lymphocytes (95 RA and 32 NR). The mean cytotoxicity of the RA lymphocytes (cytotoxic score = 0.78) did not differ significantly from that of the control lymphocytes (cytotoxic score = 1.01), with the t for the two mean cytotoxic scores being -0.63 (P > 0.5, df 125), and x2 analysis detected no differences (Table  V) . cells as contrasted to control leukocytes (Fig. 2) . All comparisons at both the 100: 1 and 10: 1 ratios demonstrate significance by x% analysis (Table VI) . In these tests the RA leukocytes were much more cytotoxic for RA synovial cells than for any other target cell. This is in contrast to the results obtained with other leukocytes. When individual results were analyzed, it was evident that the majority of highly cytotoxic reactions in the group of patients with other diseases occurred with leukocytes from patients with SLE and ankylosing spondylitis. Leukocytes from patients with gouty arthritis, degenerative joint disease, and osteopenia produced cytotoxic reactions similar to those obtained with normal individuals' leukocytes. Although leukocytes from patients with systemic lupus erythematosus and spondylitis were more cytotoxic for synovial cells than normal leukocytes, this cytotoxicity was not specific for either RA or NR target cells. These results were in contrast to those obtained with RA leukocytes (Table VII) , which produced far greater killing of RA synovial target cells than NR synovial target cells. As indicated, leukocytes from NR individuals were cytotoxic in 25% of tests on NR target cells and in 30% of tests on RA target cells, whereas RA leukocytes were cytotoxic in 39% of tests with NR target cells compared to 59% of tests with RA target cells. The difference in the cytotoxicity between control and RA leukocytes for NR target cells was not significant (25% compared to 39%), whereas the difference in cytotoxic reactions between NR leukocytes (30%) and RA leukocytes (59%) for RA target cells was highly significant. Thus, RA leukocytes were more cytotoxic than NR leukocytes, and the cytotoxic reaction of RA leukocytes was directed preferentially against RA-derived synovial target cells. Lymphocytotoxicity: RA synovial target cells. Purified lymphocytes from patients with RA were used in 159 tests and gave a mean cytotoxic score of 2.48±0.18 compared to 1.07±0.24 for the control lymphocytes used in 48 tests. The difference between mean cytotoxic scores was highly significant, t = 4.09, (P < 0.001, df 205). Tabulation of data at increasing scores confirmed After the determination that RA leukocytes were cytotoxic for RA synovial cells, separation experiments demonstrated that cell suspensions containing 97-98% lymphocytes and less than 2.5% macrophages retained all of the net cytotoxicity for synovial cells. These results strongly suggest that the cytotoxic activity is largely a property of lymphocytes. It is not known whether the effector lymphocytes are bone marrow-or thymus-derived cells, nor whether cooperation of small numbers of macrophages is required.
RESULTS
In the cytotoxic tests reported here, synovial target cells from all sources were more frequently killed by both unseparated leukocytes and lymphocytes than were fibroblasts from other sources. Leukocytes from patients with CTD, in which immune mechanisms are thought to play a pathogenic role, were more cytotoxic for synovial cells than leukocytes from normal persons. However, cytotoxicity of CTD leukocytes was as great for NR as for RA synovial cells.
Leukocytes from patients with RA were cytotoxic for NR synovial cells at about the same frequency as leukocytes from all patients with CTD and other musculoskeletal conditions were cytotoxic for both NR and RA synovial cells. In striking contrast, RA leukocytes were far more cytotoxic for RA synovial cells than NR synovial cells. When purified lymphocytes were used as aggressor cells, a lower frequency of killing was observed, but the difference in frequency of cytotoxic reactions between RA and control aggressor cells, namely the net cytotoxicity, was similar for both leukocytes and lymphocytes when RA synovial target cells were used.
The unique susceptibility of RA synovial cells to the cytotoxic effects of RA leukocytes and lymphocytes is compatible with several possible explanations. First, immune recognition of an antigen in RA-derived synovial cells in culture could be responsible for the observed reactivity. Several candidates for the putative antigen might be considered, including viruses, mycoplasmas, other microorganisms, and nonliving antigens acquired from the environment. The synovial cells may be chronically infected with one of the aforementioned agents and the cytotoxic reaction may be directed against a microbial antigen. Alternatively, one of the agents may have induced a cellular membrane change recognized by sensitized RA lymphocytes. Virus-infected cells and virus-transformed cells can be recognized and killed by sensitized lymphocytes (7, 8) . At least hypothetically, a mycoplasma or mycoplasmal-induced antigen might be detected by the cytotoxic reaction.
Alternatively, the unique reactivity of the RA synovial cells may reflect an endogenous tissue antigen, such as a disease-specific tissue antigen, a fetal synovial cell antigen derepressed by the disease process, or a histocompatibility (HLA) antigen. These antigens would presumably be inherited, but evidence to date does not suggest that RA is an inherited disease. In view of the reports of a normal distribution of HLA-A and B antigens in RA (9-12), it seems unlikely that an HLA-A or B antigen is involved, since if RA lymphocytes were responding to HLA antigens, then one would expect cytotoxic reactions as often with NR as RA synovial cells. Mixed lymphocyte culture reactivity, suggesting an unusual frequency of antigens at the HLA-D locus in patients with RA, has been reported (13) . Further investigation is required to determine whether HLA-D antigen distribution has any bearing on the cytotoxic reactions observed. To our knowledge, no studies on the HLA-C locus in RA have been published. It should be noted that the possible participation of a histocompatibility antigen in determining the specificity of the cytotoxic reaction does not exclude the participation of a virus or viral induced neo-antigen. Studies in mice have shown that the cytotoxicity of sensitized lymphocytes for virus-infected cells and tumor cells is in part determined by the H-2 antigens (14) .
Finally, the unique reactivity of RA synovial cells could be accounted for by the presence of a nonimmunologically specific stimulator in the synovial cells, unique to or present in greater amount in RA synovial cells. Although this latter possibility seems least likely, it cannot be discounted, because a recent report described the mitogenic activity of various blood components (15 Griffiths et al. suggested that the degree of cytotoxicity produced by RA or NR lynmphocytes for synovial target cells was related to the age of the target cells in culture (18) , an observation we were unable to confirm with the present data. A number of other investigators have studied the cytotoxic effects of both synovial fluid cells and periplheral white blood cells obtained from patients with CTD for a variety of target cells (18) (19) (20) (21) (22) (23) (24) (25) (26) . None has made the quantitative comparisons between RA and NR synovial cells shown lhere, and because of many variables in the techniques used, their results have little bearing on the interpretation of the present observations.
As indicated above, a number of possibilities could account for the observations made. Possible nonspecific, metabolic, or genetic effects have been considered and remain as tenable explanations; however, the data reported strongly suggest the possibility that RA lymphocytes were sensitized to an antigen(s) present on RA synovial cells. Definition of the antigen(s) requires furtlher investigation.
